The Patent Finder

RESprotect GmbH

Also on record
Records under this name other than patents RESprotect GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to RESprotect GmbH

PatentTitleStatus Expires Confidence
US 8,492,537Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy
Lapsed on the fee record
Ended Jul 23, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jul 23, 2021From the USPTO record
US 9,181,199Uracil derivatives and use thereof
Lapsed on the fee record
Ended Nov 10, 2019 · From the USPTO record
Lapsed on the fee recordEnded Nov 10, 2019From the USPTO record
US 7,713,948Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs
Lapsed on the fee record
Ended May 11, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 11, 2018From the USPTO record
US 6,589,941Utilization of 5′ substituted nucleosides for resistance formation in cytoclastic treatment, and drug containing these nucleosides, polymers, methods of use and compositions
Term ended
Term ended Jan 31, 2016 · From the USPTO record
Term endedTerm ended Jan 31, 2016From the USPTO record
US 7,122,528Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
Lapsed on the fee record
Ended Oct 17, 2010 · From the USPTO record
Lapsed on the fee recordEnded Oct 17, 2010From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited